Plexin B1 inhibits MET through direct association and regulates Shp2 expression in melanocytes

Journal of Cell Science

Volumn 126, Issue 2, 2013, Pages 688-695

  Soong, Joanne ^a   Scott, Glynis ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Hepatocyte growth factor; HGF; Melanocyte; MET; Plexin B1; Receptor tyrosine kinases; RTK

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLEXIN; PLEXIN B1; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP 2; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; MELANOMA; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; CELL MOVEMENT; HUMANS; MELANOCYTES; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, CELL SURFACE; SEMAPHORINS; SIGNAL TRANSDUCTION;

EID: 84876083536     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.119487     Document Type: Article

References (40)

1. Argast, G. M., Croy, C. H., Couts, K. L., Zhang, Z., Litman, E., Chan, D. C. and Ahn, N. G. (2009). Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells. Oncogene 28, 2697-2709.
2. Beum, P. V., Lindorfer, M. A., Hall, B. E., George, T. C., Frost, K., Morrissey, P. J. and Taylor, R. P. (2006). Quantitative analysis of protein co-localization on B cells opsonized with rituximab and complement using the ImageStream multispectral imaging flow cytometer. J. Immunol. Methods 317, 90-99.
3. Chattopadhyay, C., Ellerhorst, J. A., Ekmekcioglu, S., Greene, V. R., Davies, M. A. and Grimm, E. A. (2012). Association of activated c-Met with NRAS-mutated human melanomas. Int. J. Cancer 131, E56-E65.
4. Chong, Z. Z., Lin, S. H., Kang, J. Q. and Maiese, K. (2003). The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival. Cell. Mol. Neurobiol. 23, 561-578.
5. Conrotto, P., Valdembri, D., Corso, S., Serini, G., Tamagnone, L., Comoglio, P. M., Bussolino, F. and Giordano, S. (2005). Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105, 4321-4329.
6. Conti, E., Dottorini, T., Sarkozy, A., Tiller, G. E., Esposito, G., Pizzuti, A. and Dallapiccola, B. (2003). A novel PTPN11 mutation in LEOPARD syndrome. Hum. Mutat. 21, 654.
7. Damm, S., Koefinger, P., Stefan, M., Wels, C., Mehes, G., Richtig, E., Kerl, H., Otte, M. and Schaider, H. (2010). HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta. J. Invest. Dermatol. 130, 1893-1903.
8. Feng, G. S. (2007). Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation. Cell Res. 17, 37-41.
9. Fuchikawa, T., Nakamura, F., Fukuda, N., Takei, K. and Goshima, Y. (2009). Protein tyrosine phosphatase SHP2 is involved in Semaphorin 4D-induced axon repulsion. Biochem. Biophys. Res. Commun. 385, 6-10.
10. George, T. C., Basiji, D. A., Hall, B. E., Lynch, D. H., Ortyn, W. E., Perry, D. J., Seo, M. J., Zimmerman, C. A. and Morrissey, P. J. (2004). Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer. Cytometry A 59, 237-245.
11. Giger, R. J., Hollis, E. R., 2nd and Tuszynski, M. H. (2010). Guidance molecules in axon regeneration. Cold Spring Harb. Perspect. Biol. 2, a001867.
12. Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L. and Comoglio, P. M. (2002). The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat. Cell Biol. 4, 720-724.
13. Grossmann, K. S., Rosário, M., Birchmeier, C. and Birchmeier, W. (2010). The tyrosine phosphatase Shp2 in development and cancer. Adv. Cancer Res. 106, 53-89.
14. Haass, N. K., Smalley, K. S. and Herlyn, M. (2004). The role of altered cell-cell communication in melanoma progression. J. Mol. Histol. 35, 309-318.
15. Halaban, R., Fan, B., Ahn, J., Funasaka, Y., Gitay-Goren, H. and Neufeld, G. (1992a). Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J. Immunother. 12, 154-161.
16. Halaban, R., Rubin, J. S., Funasaka, Y., Cobb, M., Boulton, T., Faletto, D., Rosen, E., Chan, A., Yoko, K., White, W. et al. (1992b). Met and hepatocyte growth factor/ scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7, 2195-2206.
17. Halaban, R., Rubin, J. S. and White, W. (1993). met and HGF-SF in normal melanocytes and melanoma cells. EXS 65, 329-339.
18. Han, S. U., Lee, H. Y., Lee, J. H., Kim, W. H., Nam, H., Kim, H., Cho, Y. K., Kim, M. W. and Lee, K. U. (2005). Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Ann. Surg. 242, 676-683.
19. Hatanaka, K., Lanahan, A. A., Murakami, M., Simons, M. (2012). Fibroblast growth factor signaling potentiates VE-cadherin stability and adherens junctions by regulating Shp2. PLoS ONE. 7, e37600.
20. Hov, H., Holt, R. U., Ro, T. B., Fagerli, U. M., Hjorth-Hansen, H., Baykov, V., Christensen, J. G., Waage, A., Sundan, A. and Borset, M. (2004). A selective cmet inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Clin. Cancer Res. 10, 6686-6694.
21. Kenessey, I., Keszthelyi, M., Krámer, Z., Berta, J., Adám, A., Dobos, J., Mildner, M., Flachner, B., Cseh, S., Barna, G. et al. (2010). Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma. Curr. Cancer Drug Targets 10, 332-342.
22. Koefinger, P., Wels, C., Joshi, S., Damm, S., Steinbauer, E., Beham-Schmid, C., Frank, S., Bergler, H. and Schaider, H. (2011). The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators. Pigment Cell Melanoma Res. 24, 382-385.
23. Li, J., Reed, S. A. and Johnson, S. E. (2009). Hepatocyte growth factor (HGF) signals through SHP2 to regulate primary mouse myoblast proliferation. Exp. Cell Res. 315, 2284-2292.
24. Lin, S., Rusciano, D., Lorenzoni, P., Hartmann, G., Birchmeier, W., Giordano, S., Comoglio, P. and Burger, M. M. (1998). C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells. Clin. Exp. Metastasis 16, 253-265.
25. Neel, B. G., Gu, H. and Pao, L. (2003). The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293.
26. Oinuma, I., Ishikawa, Y., Katoh, H. and Negishi, M. (2004). The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305, 862-865.
27. Pasterkamp, R. J. and Giger, R. J. (2009). Semaphorin function in neural plasticity and disease. Curr. Opin. Neurobiol. 19, 263-274.
28. Rajadurai, C. V., Havrylov, S., Zaoui, K., Vaillancourt, R., Stuible, M., Naujokas, M., Zuo, D., Tremblay, M. L. and Park, M. (2012). Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia. J. Cell Sci. 125, 2940-2953.
29. Saito, Y., Oinuma, I., Fujimoto, S. and Negishi, M. (2009). Plexin-B1 is a GTPase activating protein for M-Ras, remodelling dendrite morphology. EMBO Rep. 10, 614- 621.
30. Schaeper, U., Gehring, N. H., Fuchs, K. P., Sachs, M., Kempkes, B. and Birchmeier, W. (2000). Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149, 1419-1432.
31. Scott, G. A., McClelland, L. A., Fricke, A. F. and Fender, A. (2009). Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J. Invest. Dermatol. 129, 954-963.
32. Seki, N., Hashimoto, N., Taira, M., Yagi, S., Yoshida, Y., Ishikawa, K., Suzuki, Y., Sano, H., Horiuchi, S., Yoshida, S. et al. (2007). Regulation of Src homology 2- containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes. Metabolism 56, 1591-1598.
33. Soong, J., Chen, Y., Shustef, E. M. and Scott, G. A. (2012). Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth. J. Invest. Dermatol. 132, 1230-1238.
34. Stevens, L., McClelland, L., Fricke, A., Williamson, M., Kuo, I. and Scott, G. (2010). Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met. J. Invest. Dermatol. 130, 1636-1645.
35. Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G. I., Song, H., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M. et al. (1999). Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71-80.
36. Thomas, J., Liu, T., Cotter, M. A., Florell, S. R., Robinette, K., Hanks, A. N. and Grossman, D. (2007). Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Res. 67, 5172-5178.
37. Villanueva, J. and Herlyn, M. (2008). Melanoma and the tumor microenvironment. Curr. Oncol. Rep. 10, 439-446.
38. Wang, Y., He, H., Srivastava, N., Vikarunnessa, S., Chen, Y. B., Jiang, J., Cowan, C. W. and Zhang, X. (2012). Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci. Signal. 5, ra6.
39. Yang, W., Klaman, L. D., Chen, B., Araki, T., Harada, H., Thomas, S. M., George, E. L. and Neel, B. G. (2006). An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10, 317-327.
40. Yang, Y. H., Zhou, H., Binmadi, N. O., Proia, P. and Basile, J. R. (2011). Plexin-B1 activates NF-kB and IL-8 to promote a pro-angiogenic response in endothelial cells. PLoS ONE 6, e25826.